Body fat is rich in healing properties. Our devices offer clinic-based personalized Anti-aging Medicine therapies using body’s natural fat.
Ask your doctor about:
FDA cleared – MiniTC™ used for Microfat isolation
CE Mark pending – Mini-Stem System™ used for Stromal Vascular Fraction (SVF) isolation
Benefits
MiniTC™ (USA) and Mini-Stem System™ (EU and other countries) have applications in medical aesthetics, plastic and reconstructive surgery, orthopedics and wound healing among others.
Restores fullness and shape; adds volume; decreases skin sag; erases stretch marks.
Rejuvenation of face; improves skin texture, wrinkles, fine lines and acne scars; adds volume.
Improves blood circulation to chronic wounds; decreases inflammation and pain; promotes faster healing and regeneration
Reduces pain; decreases inflammation; helps repair cartilage and soft tissue injuries; improves healing and prompts return to active lifestyle.
MiniTC™
MiniTC™ is a FDA-cleared portable medical device used for processing and isolation of fragmented and purified fat grafts (microfat) in any clinic setting. The device can be used in a broad range of therapeutic areas, such as medical aesthetics, plastic and reconstructive surgeries, orthopedics and wound care.
Features:
- FDA cleared, patented, disposable, closed loop medical device that can be used in various clinical settings for many indications.
- Enables point-of-care fat tissue processing to isolate fragmented and purified fat grafts (microfat)
Microfat
Microfat is your own processed and fragmented fat, which is rich in regenerative cells. Microfat preserves the integrity of fat tissue and the stromal (stem) cells within its natural niche which helps in the reconstruction, rejuvenation and healing of tissues. Microfat can then be applied or injected to areas of injury, inflammation or for aesthetic contouring.
Mini-Stem System™
Mini-Stem System™ is a CE-mark pending medical device for processing and isolation of fat-derived stromal (stem) vascular fraction (SVF) in any clinic setting. The device can be used in a broad range of therapeutic areas, such as medical aesthetics, plastic & reconstructive surgeries, orthopedics and wound care.
Features:
- CE-mark pending, patented, disposable, closed loop medical device that can be used in various clinical settings.
- Enables point-of-care fat tissue processing to stem cell fraction (SVF).
Stromal Vascular Fraction (SVF)
SVF is a cellular product rich in your own fat-derived stem cells that have been shown to possess powerful anti-inflammatory and immunomodulatory functions. SVF, when injected, helps in the reconstruction, regeneration and healing of tissues.
Pipeline Stem Cell Therapy
Based on our technology, Jointechlabs is developing therapies for unmet medical needs. Our first therapeutic in clinical development JTL-T-01 is a proprietary injectable stem cell scaffold as a biologic therapy for osteoarthritis, for approval under the FDA’s fast-track program. JTL-T-01 has been designed as an autologous point-of-care therapy enabling the patient’s own stem cells to be locally injected into the affected joints.
Team
Nathan Katz PhD, ALBB Co-founder, Chief Executive Officer & Chief Technical Officer
Nathan is an inventor, and entrepreneur with 30 years of experience in the fields of stem cells, medical device, and human genetics. His record includes peer-reviewed publications and scientific presentations. He led the company to its first FDA clearance, massive IP portfolio, NIH grant awards, and efficient R & D and manufacturing. Nathan has built a management team of dedicated professionals and established collaborations with most prominent experts in the regenerative medicine field.
Nishit Pancholi MD, MS Co-founder, Chief Operating Officer & Chief Medical Officer
Nishit is an entrepreneurial leader with 15+ years of experience in regenerative medicine, and strong knowledge of business operations. His approach based on scientific rationale, and commercial opportunity is pivotal in the company’s regulatory approval strategies across clinical indications, and geographies. Nishit leads development and execution utilizing available resources to meet ongoing business needs while managing relationships with advisors, vendors, and key stake holders.
Jonathan Schwartz President
Jonathan has more than 39 years of experience in the healthcare space. Since 2010 he has focused exclusively on new technologies related to Regenerative Medicine and has been instrumental in their global commercialization. He is acknowledged worldwide as a pioneer in the field and has lectured extensively across the Globe.
Thomas Lawson FDA Consultant
Thom has over 30 years of experience in regulatory affairs, in both start-up and Fortune 500 companies. He has written and coordinated over 50 regulatory filings for commercialization of medical devices in 27 countries, including authoring over thirty-five 510(k) submissions.
Betsy Levy Senior PR/Communications Advisor
A seasoned public relations specialist, Betsy has an exceptional track record of managing communications for healthcare companies. Stemming from her years on agency side, in-house role at Genentech and as a consultant to startups, Betsy provides clients with strategic advisory for announcement of key milestones, thought leadership development and reputation management.
Steven Ivy Business and Corporate Counsel
Attorney Steven Ivy is a member of the Illinois Bar, and a member of the Bar of the USPTO. His combined 28 years of programming, engineering, management, business ownership, financial planning, and legal experience, makes him one of the most uniquely qualified business attorneys in the country.
Amir Penn Patent Attorney
Mr. Penn is a Partner with the law firm, Lempia Summerfield Katz LLC and has over 25 years of experience assisting companies in managing their intellectual property rights. Mr. Penn is licensed as a patent attorney and represents Jointechlabs Inc. before the US Patent Office, has extensive patent prosecution experience regarding medical and life sciences inventions, and focuses on obtaining patents that align with business strategy.
Karl Nobert Regulatory Counsel
Karl focuses his practice in FDA Regulatory law, representing U.S. and international clients in the food and drug industries for pharmaceuticals and OTC drugs, biologics, medical devices. He has vast experience in the areas of regenerative medicine and has counseled numerous clients seeking FDA approval for cellular-based products to treat both humans and animals.
Testimonial
Chadwick Prodromos Founder at Illinois Sports Medicine
Jointechlabs has the best product at the best price in the autologous regenerative medicine fi eld. I know all of these products. I will use them as a vendor, I am a physician. My interest is in helping patients, not generating revenue from an investment. The management team is also highly qualified, experienced and communicates well.
Enrico Guarino CEO at Medithread
I appreciate the scientific honesty of the team. All their work is based on scientific evidence and objective results. I find it really important that they share their research with other colleagues and that they are open to accepting suggestions and ideas from other colleagues. This makes the difference between teams that work only for economic results versus those that care about scientific research. Enrico Guarino
William Murrell Consultant Orthopaedic Sports Medicine at Healthpoint, UAE
Great system!!! Very versatile, awesome hands too!! So likely great outcome!!
Joseph Purita Chief Medical Officer of the Institute of Regenerative medicine at Institute of Regenerative Medicine
Good product, good price, good combination